CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 11,640 shares, a drop of 87.3% from the September 30th total of 91,840 shares. Based on an average daily trading volume, of 571 shares, the short-interest ratio is presently 20.4 days.
CanSino Biologics Price Performance
Shares of CanSino Biologics stock opened at C$3.95 on Tuesday. The business has a 50-day simple moving average of C$3.97 and a 200 day simple moving average of C$3.76. CanSino Biologics has a one year low of C$2.60 and a one year high of C$5.60.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biotechnology company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies intended to address infectious diseases, with activities spanning early-stage research, clinical development, regulatory approval and commercial production.
CanSino’s portfolio includes Convidecia, an adenovirus-based COVID-19 vaccine, and Convidecia Air, an inhaled version designed for respiratory immunization.
Recommended Stories
- Five stocks we like better than CanSino Biologics
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
